Insmed Inc. buy JPMorgan Chase & Co.
Start price
22.11.24
/
50%
€71.00
Target price
22.11.25
€79.67
Performance (%)
145.07%
End price
23.11.25
€174.00
Summary
This prediction ended on 23.11.25 with a price of €174.00. The BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. saw massive gains of 145.07%. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 0.620% | 0.620% | 98.034% |
| iShares Core DAX® | 0.423% | 5.706% | 4.696% |
| iShares Nasdaq 100 | 4.096% | 16.639% | 38.946% |
| iShares Nikkei 225® | 4.469% | 18.343% | 50.386% |
| iShares S&P 500 | 1.788% | 9.644% | 26.896% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $74.00 to $83.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten